
Sydney B. Rosen, MPA
Research Professor, Global Health - Boston University School of Public Health
Biography
Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health at the Boston University School of Public Health and a Co-Director of the Health Economics and Epidemiology Research Office (HE2RO) of the University of the Witwatersrand in Johannesburg, South Africa. Her research addresses the economic consequences of the HIV/AIDS epidemic, and in particular the outcomes, costs, cost-effectiveness, and benefits of HIV and TB care and treatment interventions and models of service delivery. She is the principal investigator of multiple USAID-, NIH-, and foundation-supported studies and evaluations in South Africa and has worked extensively in Zambia and Kenya. She is also the author of policy and review papers on the business response to AIDS, the rationing of antiretroviral therapy, and the retention of patients in HIV/AIDS care and treatment programs. Her current projects include AMBIT, EVIDENCE, MATI, and EQUIP, all described on the BUSPH website. Professor Rosen’s technical training is in policy analysis and applied economics. She holds a BA magna cum laude from Harvard University and an MPA from the Kennedy School of Government at Harvard.
Other Positions
- Co-Division Head, Health Economics and Epidemiology Research Office - University of the Witwatersrand
Education
- Harvard University, MPA Field of Study: Economics
- Harvard University, AB Field of Study: History
Publications
- Published on 3/18/2021
Larson BA, Pascoe SJS, Huber A, Long LC, Murphy J, Miot J, Fraser-Hurt N, Fox MP, Rosen S. Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis. PLoS One. 2021; 16(3):e0248551. PMID: 33735206.
Read At: PubMed
- Published on 3/1/2021
Scott NA, Maskew M, Fong RM, Olson IE, Brennan AT, Fox MP, Vezi L, Ehrenkranz PD, Rosen S. Patient Perspectives of Quality of the Same-Day Antiretroviral Therapy Initiation Process in Gauteng Province, South Africa: Qualitative Dominant Mixed-Methods Analysis of the SLATE II Trial. Patient. 2021 Mar; 14(2):175-186. PMID: 32909218.
Read At: PubMed
- Published on 2/2/2021
Nichols BE, Cele R, Jamieson L, Long LC, Siwale Z, Banda P, Moyo C, Rosen S. Community-based delivery of HIV treatment in Zambia: costs and outcomes. AIDS. 2021 02 02; 35(2):299-306. PMID: 33170578.
Read At: PubMed
- Published on 11/1/2020
Long L, Kuchukhidze S, Pascoe S, Nichols BE, Fox MP, Cele R, Govathson C, Huber AN, Flynn D, Rosen S. Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review. J Int AIDS Soc. 2020 11; 23(11):e25640. PMID: 33247517.
Read At: PubMed
- Published on 10/9/2020
Min Thaung Y, Chasela CS, Chew KW, Minior T, Lwin AA, Sein YY, Drame N, Marange F, van der Horst C, Thwin HT, Freiman MJ, Gandhi MM, Bijl M, Wose Kinge C, Rosen S, Thura S, Mohamed S, Xulu T, Naing AY, Barralon M, Cavenaugh C, Kyi KP, Sanne I. Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in Myanmar. J Viral Hepat. 2021 01; 28(1):147-158. PMID: 32935438.
Read At: PubMed
- Published on 9/6/2020
Brennan A, Maskew M, Larson BA, Tsikhutsu I, Bii M, Vezi L, Fox M, Venter WDF, Ehrenkranz PD, Rosen S. Prevalence of TB symptoms, diagnosis and treatment among people living with HIV (PLHIV) not on ART presenting at outpatient clinics in South Africa and Kenya: baseline results from a clinical trial. BMJ Open. 2020 09 06; 10(9):e035794. PMID: 32895266.
Read At: PubMed
- Published on 9/1/2020
Nichols BE, Offorjebe OA, Cele R, Shaba F, Balakasi K, Chivwara M, Hoffman RM, Long LC, Rosen S, Dovel K. Economic evaluation of facility-based HIV self-testing among adult outpatients in Malawi. J Int AIDS Soc. 2020 09; 23(9):e25612. PMID: 32909387.
Read At: PubMed
- Published on 8/27/2020
Maskew M, Brennan AT, Fox MP, Vezi L, Venter WDF, Ehrenkranz P, Rosen S. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial. PLoS Med. 2020 08; 17(8):e1003226. PMID: 32853271.
Read At: PubMed
- Published on 7/29/2020
Rosen S, Grimsrud A, Ehrenkranz P, Katz I. Models of service delivery for optimizing a patient's first six months on antiretroviral therapy for HIV: an applied research agenda. Gates Open Res. 2020; 4:116. PMID: 32875281.
Read At: PubMed
- Published on 7/1/2020
Larson BA, Pascoe SJ, Huber A, Long LC, Murphy J, Miot J, Fox MP, Fraser-Hurt N, Rosen S. Will differentiated care for stable HIV patients reduce healthcare systems costs? J Int AIDS Soc. 2020 07; 23(7):e25541. PMID: 32686911.
Read At: PubMed
View 116 more publications:View Full Profile at BUMC
News & In the Media
- Published on November 25, 2019
-
Published on June 3, 2019
Researcher Who Exposed Flint Water Crisis to SPH Grads: “Stand Up for What Is Right”
- Published on November 28, 2017
- Published on November 13, 2017
- Published on October 2, 2017
- Published on September 12, 2017
- Published on July 5, 2017
- Published on January 3, 2017
- Published on May 10, 2016
-
Published on March 8, 2016
HIV Treatment Costs High at Inpatient Care Facilities in South Africa
-
Published on October 8, 2015
Researchers Partner with World Bank and South African Government